{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:33:16Z","timestamp":1791275596612,"version":"4.1.0"},"reference-count":115,"publisher":"Elsevier BV","issue":"4-5","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Differentiation"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.diff.2011.04.005","type":"journal-article","created":{"date-parts":[[2011,8,22]],"date-time":"2011-08-22T06:05:27Z","timestamp":1313993127000},"page":"244-252","source":"Crossref","is-referenced-by-count":44,"title":["Cholesterol and benign prostate disease"],"prefix":"10.1016","volume":"82","author":[{"given":"Michael R.","family":"Freeman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith R.","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"34","key":"10.1016\/j.diff.2011.04.005_bib92","first-page":"1556","article-title":"Prostatic hypertrophy treated with antimycotics. An orientation study","volume":"132","author":"Aalkjaer","year":"1970","journal-title":"Ugeskr. Laeg."},{"issue":"1","key":"10.1016\/j.diff.2011.04.005_bib93","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1464-410X.1977.tb04526.x","article-title":"A double-blind trial of the effects of candicidin on patients with benign prostatic hypertrophy","volume":"49","author":"Abrams","year":"1977","journal-title":"Br. J. Urol."},{"issue":"13","key":"10.1016\/j.diff.2011.04.005_bib27","doi-asserted-by":"crossref","first-page":"6238","DOI":"10.1158\/0008-5472.CAN-07-0288","article-title":"Cholesterol sensitivity of endogenous and myristoylated Akt","volume":"67","author":"Adam","year":"2007","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.diff.2011.04.005_bib77","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0090-4295(98)00390-2","article-title":"Elevated levels of proinflammatory cytokines in the semen of patients with chronic prostatitis\/chronic pelvic pain syndrome","volume":"52","author":"Alexander","year":"1998","journal-title":"Urology"},{"issue":"2","key":"10.1016\/j.diff.2011.04.005_bib76","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1046\/j.1365-2249.2002.01853.x","article-title":"Autoimmune T cell responses to seminal plasma in chronic pelvic pain syndrome (CPPS)","volume":"128","author":"Batstone","year":"2002","journal-title":"Clin. Exp. Immunol."},{"issue":"2","key":"10.1016\/j.diff.2011.04.005_bib42","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s10552-010-9691-6","article-title":"Modifiable risk factors for prostate cancer mortality in London: forty years of follow-up in the Whitehall study","volume":"22","author":"Batty","year":"2011","journal-title":"Cancer Causes Control"},{"issue":"5","key":"10.1016\/j.diff.2011.04.005_bib54","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/j.1464-410X.2006.06400.x","article-title":"Atherosclerosis as a risk factor for benign prostatic hyperplasia","volume":"98","author":"Berger","year":"2006","journal-title":"Br. J. Urol. Int."},{"issue":"4","key":"10.1016\/j.diff.2011.04.005_bib34","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/ijc.23550","article-title":"Statin use and the risk of prostate cancer: a metaanalysis of 6 randomized clinical trials and 13 observational studies","volume":"123","author":"Bonovas","year":"2008","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.diff.2011.04.005_bib83","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/ng823","article-title":"Germline mutations in the ribonuclease L gene in families showing linkage with HPC1","volume":"30","author":"Carpten","year":"2002","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.diff.2011.04.005_bib64","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1161\/01.CIR.0000022843.76104.01","article-title":"Simvastatin reduces neointimal thickening in low-density lipoprotein receptor-deficient mice after experimental angioplasty without changing plasma lipids","volume":"106","author":"Chen","year":"2002","journal-title":"Circulation"},{"issue":"40","key":"10.1016\/j.diff.2011.04.005_bib48","doi-asserted-by":"crossref","first-page":"29584","DOI":"10.1074\/jbc.M703310200","article-title":"Phosphoinositide 3-kinase-independent non-genomic signals transit from the androgen receptor to Akt1 in membrane raft microdomains","volume":"282","author":"Cinar","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.diff.2011.04.005_bib74","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1046\/j.1365-2249.1998.00678.x","article-title":"Recognition of prostate-specific antigenic peptide determinants by human CD4 and CD8 T cells","volume":"114","author":"Corman","year":"1998","journal-title":"Clin. Exp. Immunol."},{"issue":"3","key":"10.1016\/j.diff.2011.04.005_bib107","doi-asserted-by":"crossref","first-page":"99","DOI":"10.5551\/jat.14.99","article-title":"Zetia: inhibition of Niemann-Pick C1 Like 1 (NPC1L1) to reduce intestinal cholesterol absorption and treat hyperlipidemia","volume":"14","author":"Davis","year":"2007","journal-title":"J. Atheroscler. Thromb."},{"issue":"4","key":"10.1016\/j.diff.2011.04.005_bib3","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nrc2090","article-title":"Inflammation in prostate carcinogenesis","volume":"7","author":"De Marzo","year":"2007","journal-title":"Nat. Rev. Cancer"},{"issue":"14","key":"10.1016\/j.diff.2011.04.005_bib50","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.4161\/cc.7.14.6475","article-title":"Caveolin-1 interacts with a lipid raft-associated population of fatty acid synthase","volume":"7","author":"Di Vizio","year":"2008","journal-title":"Cell Cycle"},{"issue":"18","key":"10.1016\/j.diff.2011.04.005_bib7","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1056\/NEJMc060691","article-title":"Saw palmetto for benign prostatic hyperplasia","volume":"354","author":"Dimitrakov","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.diff.2011.04.005_bib4","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.urology.2005.12.015","article-title":"Management of chronic prostatitis\/chronic pelvic pain syndrome: an evidence-based approach","volume":"67","author":"Dimitrakov","year":"2006","journal-title":"Urology"},{"issue":"6","key":"10.1016\/j.diff.2011.04.005_bib38","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0021-9681(81)90030-8","article-title":"Serum cholesterol and risk of death from cancer and other causes in three Chicago epidemiological studies","volume":"34","author":"Dyer","year":"1981","journal-title":"J. Chronic Dis."},{"issue":"8","key":"10.1016\/j.diff.2011.04.005_bib6","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1464-410X.2008.07717.x","article-title":"Progression of benign prostatic hyperplasia: systematic review of the placebo arms of clinical trials","volume":"102","author":"Emberton","year":"2008","journal-title":"Br. J. Urol. Int."},{"issue":"8","key":"10.1016\/j.diff.2011.04.005_bib20","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1210\/en.2004-0079","article-title":"Hedgehog signaling promotes prostate xenograft tumor growth","volume":"145","author":"Fan","year":"2004","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.diff.2011.04.005_bib47","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/jnci\/djm286","article-title":"The association between statins and cancer incidence in a veterans population","volume":"100","author":"Farwell","year":"2008","journal-title":"J. Natl. Cancer Inst."},{"issue":"6","key":"10.1016\/j.diff.2011.04.005_bib9","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1373\/clinchem.2007.100156","article-title":"The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences","volume":"54","author":"de Ferranti","year":"2008","journal-title":"Clin. Chem."},{"issue":"11","key":"10.1016\/j.diff.2011.04.005_bib31","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1158\/1055-9965.EPI-07-0197","article-title":"Statin use and risk of prostate cancer in the California men's health study cohort","volume":"16","author":"Flick","year":"2007","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"1","key":"10.1016\/j.diff.2011.04.005_bib53","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/jcb.10724","article-title":"Cholesterol and prostate cancer","volume":"91","author":"Freeman","year":"2004","journal-title":"J. Cell Biochem."},{"issue":"4","key":"10.1016\/j.diff.2011.04.005_bib89","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1073\/pnas.60.4.1201","article-title":"The effect of polyene macrolides on the prostate gland and canine prostatic hyperplasia","volume":"60","author":"Gordon","year":"1968","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"12","key":"10.1016\/j.diff.2011.04.005_bib32","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1200\/JCO.2004.02.027","article-title":"The risk of cancer in users of statins","volume":"22","author":"Graaf","year":"2004","journal-title":"J. Clin. Oncol."},{"issue":"23","key":"10.1016\/j.diff.2011.04.005_bib43","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1001\/jama.288.23.2998","article-title":"Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT-LLT)","volume":"288","author":"Group A.O.a.C.f.t.A.C.R.","year":"2002","journal-title":"Jama"},{"issue":"9326","key":"10.1016\/j.diff.2011.04.005_bib44","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF heart protection study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial","volume":"360","author":"Group","year":"2002","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.diff.2011.04.005_bib105","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1158\/1055-9965.EPI-07-0306","article-title":"Do statins affect androgen levels in men? Results from the Boston area community health survey","volume":"16","author":"Hall","year":"2007","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"2","key":"10.1016\/j.diff.2011.04.005_bib60","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000052430","article-title":"Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia","volume":"39","author":"Hammarsten","year":"2001","journal-title":"Eur. Urol."},{"issue":"11","key":"10.1016\/j.diff.2011.04.005_bib36","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/0021-9681(86)90034-2","article-title":"Serum cholesterol and the incidence of cancer in a large cohort","volume":"39","author":"Hiatt","year":"1986","journal-title":"J. Chronic Dis."},{"issue":"11","key":"10.1016\/j.diff.2011.04.005_bib21","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1242\/dev.000729","article-title":"Region-specific requirement for cholesterol modification of sonic hedgehog in patterning the telencephalon and spinal cord","volume":"134","author":"Huang","year":"2007","journal-title":"Development"},{"issue":"2","key":"10.1016\/j.diff.2011.04.005_bib39","first-page":"199","article-title":"The impact of modifiable risk factors on mortality from prostate cancer in populations of the Asia-Pacific region","volume":"8","author":"Huxley","year":"2007","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"11","key":"10.1016\/j.diff.2011.04.005_bib46","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1158\/1055-9965.EPI-07-0448","article-title":"Cholesterol-lowering drugs and advanced prostate cancer incidence in a large U.S. cohort","volume":"16","author":"Jacobs","year":"2007","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"3","key":"10.1016\/j.diff.2011.04.005_bib63","first-page":"503","article-title":"Mouse models of experimental atherosclerosis","volume":"55","author":"Jawien","year":"2004","journal-title":"J. Physiol. Pharmacol."},{"issue":"1","key":"10.1016\/j.diff.2011.04.005_bib94","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/BF00272701","article-title":"Candicidin treatment of prostatism: a prospective double-blind placebo-controlled study","volume":"11","author":"Jensen","year":"1983","journal-title":"Urol. Res."},{"issue":"1","key":"10.1016\/j.diff.2011.04.005_bib95","first-page":"26","article-title":"Candicidin treatment of benign hypertrophy of the prostate","volume":"144","author":"Jensen","year":"1982","journal-title":"Ugeskr. Laeg."},{"issue":"5","key":"10.1016\/j.diff.2011.04.005_bib108","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.amjcard.2003.11.040","article-title":"Effectiveness of ezetimibe in clinical practice","volume":"93","author":"Jurado","year":"2004","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.diff.2011.04.005_bib62","article-title":"An insidious risk factor for cardiovascular disease: benign prostatic hyperplasia","author":"Karatas","year":"2009","journal-title":"Int. J. Cardiol."},{"issue":"7009","key":"10.1016\/j.diff.2011.04.005_bib19","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nature02962","article-title":"Hedgehog signalling in prostate regeneration, neoplasia and metastasis","volume":"431","author":"Karhadkar","year":"2004","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.diff.2011.04.005_bib96","first-page":"116","article-title":"Effect of candicidin on the human benign hypertrophied prostate gland","volume":"58","author":"Keshin","year":"1973","journal-title":"Int. Surg."},{"issue":"2","key":"10.1016\/j.diff.2011.04.005_bib49","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1210\/en.2003-0772","article-title":"Involvement of cholesterol-rich lipid rafts in interleukin-6-induced neuroendocrine differentiation of LNCaP prostate cancer cells","volume":"145","author":"Kim","year":"2004","journal-title":"Endocrinology"},{"issue":"8","key":"10.1016\/j.diff.2011.04.005_bib72","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1210\/en.2008-1782","article-title":"A signaling network in phenylephrine-induced benign prostatic hyperplasia","volume":"150","author":"Kim","year":"2009","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.diff.2011.04.005_bib97","first-page":"36","article-title":"Early results of the use of levorin in prostatic adenoma","volume":"18","author":"Kliucharev","year":"1972","journal-title":"Vopr. Onkol."},{"issue":"6","key":"10.1016\/j.diff.2011.04.005_bib37","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/0895-4356(88)90056-X","article-title":"Serum cholesterol and risk of cancer in a cohort of 39,000 men and women","volume":"41","author":"Knekt","year":"1988","journal-title":"J. Clin. Epidemiol."},{"issue":"8","key":"10.1016\/j.diff.2011.04.005_bib109","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0195-668X(02)00807-2","article-title":"Effects of ezetimibe, a new cholesterol absorption inhibitor, on plasma lipids in patients with primary hypercholesterolemia","volume":"24","author":"Knopp","year":"2003","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.diff.2011.04.005_bib14","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1083\/jcb.200811059","article-title":"Lattices, rafts, and scaffolds: domain regulation of receptor signaling at the plasma membrane","volume":"185","author":"Lajoie","year":"2009","journal-title":"J. Cell Biol."},{"issue":"2","key":"10.1016\/j.diff.2011.04.005_bib17","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1006\/dbio.2002.0774","article-title":"Sonic hedgehog activates mesenchymal Gli1 expression during prostate ductal bud formation","volume":"249","author":"Lamm","year":"2002","journal-title":"Dev. Biol."},{"issue":"9","key":"10.1016\/j.diff.2011.04.005_bib26","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/nchembio.103","article-title":"Raft nanodomains contribute to Akt\/PKB plasma membrane recruitment and activation","volume":"4","author":"Lasserre","year":"2008","journal-title":"Nat. Chem. Biol."},{"issue":"5","key":"10.1016\/j.diff.2011.04.005_bib59","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1046\/j.1464-410X.1997.00149.x","article-title":"A high-risk group for prostatism: a population-based epidemiological study in Korea","volume":"79","author":"Lee","year":"1997","journal-title":"Br. J. Urol."},{"issue":"12","key":"10.1016\/j.diff.2011.04.005_bib81","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1038\/sj.onc.1207344","article-title":"Interleukin-8 confers androgen-independent growth and migration of LNCaP: differential effects of tyrosine kinases Src and FAK","volume":"23","author":"Lee","year":"2004","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.diff.2011.04.005_bib22","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.2353\/ajpath.2006.050959","article-title":"Elevated levels of cholesterol-rich lipid rafts in cancer cells are correlated with apoptosis sensitivity induced by cholesterol-depleting agents","volume":"168","author":"Li","year":"2006","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.diff.2011.04.005_bib52","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1158\/0008-5472.CAN-08-3520","article-title":"The origins of breast cancer prognostic gene expression profiles","volume":"69","author":"Lukes","year":"2009","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.diff.2011.04.005_bib115","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/pros.10087","article-title":"Gene expression signature of benign prostatic hyperplasia revealed by cDNA microarray analysis","volume":"51","author":"Luo","year":"2002","journal-title":"Prostate"},{"issue":"1","key":"10.1016\/j.diff.2011.04.005_bib80","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1677\/ERC-08-0174","article-title":"Interleukin-6 stimulation of growth of prostate cancer in vitro and in vivo through activation of the androgen receptor","volume":"16","author":"Malinowska","year":"2009","journal-title":"Endocr. Relat. Cancer"},{"issue":"7203","key":"10.1016\/j.diff.2011.04.005_bib69","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.diff.2011.04.005_bib10","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/BF03347581","article-title":"Type 2 diabetes mellitus in children and adolescents","volume":"28","author":"Marcovecchio","year":"2005","journal-title":"J. Endocrinol. Invest."},{"issue":"1","key":"10.1016\/j.diff.2011.04.005_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0021-9150(02)00330-1","article-title":"A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia","volume":"168","author":"Marks","year":"2003","journal-title":"Atherosclerosis"},{"issue":"10","key":"10.1016\/j.diff.2011.04.005_bib2","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/j.1525-1497.2001.01223.x","article-title":"Quality of life is impaired in men with chronic prostatitis: the chronic prostatitis collaborative research network","volume":"16","author":"McNaughton Collins","year":"2001","journal-title":"J. Gen. Intern. Med."},{"issue":"6","key":"10.1016\/j.diff.2011.04.005_bib102","doi-asserted-by":"crossref","first-page":"591","DOI":"10.7164\/antibiotics.33.591","article-title":"Characterization of aromatic heptaene macrolide antibiotics by high performance liquid chromatography","volume":"33","author":"Mechlinski","year":"1980","journal-title":"J. Antibiot. (Tokyo)"},{"issue":"2","key":"10.1016\/j.diff.2011.04.005_bib56","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.eururo.2007.02.032","article-title":"Atorvastatin treatment for men with lower urinary tract symptoms and benign prostatic enlargement","volume":"52","author":"Mills","year":"2007","journal-title":"Eur. Urol."},{"issue":"1","key":"10.1016\/j.diff.2011.04.005_bib41","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10552-009-9434-8","article-title":"Association between plasma total cholesterol concentration and incident prostate cancer in the CLUE II cohort","volume":"21","author":"Mondul","year":"2010","journal-title":"Cancer Causes Control"},{"issue":"5","key":"10.1016\/j.diff.2011.04.005_bib70","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1159\/000020190","article-title":"Effect of inflammation and benign prostatic enlargement on total and percent free serum prostatic specific antigen","volume":"37","author":"Morote","year":"2000","journal-title":"Eur. Urol."},{"issue":"2","key":"10.1016\/j.diff.2011.04.005_bib75","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.clim.2005.03.011","article-title":"Presence of INFgamma-secreting lymphocytes specific to prostate antigens in a group of chronic prostatitis patients","volume":"116","author":"Motrich","year":"2005","journal-title":"Clin. Immunol."},{"issue":"8 Suppl. 2","key":"10.1016\/j.diff.2011.04.005_bib8","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/j.amjmed.2008.05.025","article-title":"Educating patients about lifestyle modifications for prostate health","volume":"121","author":"Moyad","year":"2008","journal-title":"Am. J. Med."},{"issue":"11","key":"10.1016\/j.diff.2011.04.005_bib33","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1158\/1055-9965.EPI-07-0599","article-title":"Cholesterol-lowering drugs and prostate cancer risk: a population-based case-control study","volume":"16","author":"Murtola","year":"2007","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"1","key":"10.1016\/j.diff.2011.04.005_bib78","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0022-5347(05)67497-6","article-title":"IL-1beta and TNF-alpha in prostatic secretions are indicators in the evaluation of men with chronic prostatitis","volume":"164","author":"Nadler","year":"2000","journal-title":"J. Urol."},{"issue":"1","key":"10.1016\/j.diff.2011.04.005_bib15","doi-asserted-by":"crossref","first-page":"102","DOI":"10.4049\/jimmunol.182.1.102","article-title":"CD28 signaling in T regulatory precursors requires p56lck and rafts integrity to stabilize the Foxp3 message","volume":"182","author":"Nazarov-Stoica","year":"2009","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.diff.2011.04.005_bib88","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1016\/S0021-9258(19)45558-0","article-title":"Studies on the biological properties of polyene antibiotics. Evidence for the direct interaction of filipin with cholesterol","volume":"247","author":"Norman","year":"1972","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.diff.2011.04.005_bib101","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/0090-4295(74)90113-7","article-title":"Efficacy of candicidin in benign prostatic hyperplasia","volume":"4","author":"Orkin","year":"1974","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.diff.2011.04.005_bib55","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1464-410X.2007.07332.x","article-title":"Lipids, lipoproteins and the risk of benign prostatic hyperplasia in community-dwelling men","volume":"101","author":"Parsons","year":"2008","journal-title":"Br. J. Urol. Int."},{"issue":"4","key":"10.1016\/j.diff.2011.04.005_bib110","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.juro.2010.05.083","article-title":"Ezetimibe reduces enlarged prostate in an animal model of benign prostatic hyperplasia","volume":"184","author":"Pelton","year":"2010","journal-title":"J. Urol."},{"issue":"2","key":"10.1016\/j.diff.2011.04.005_bib79","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.eururo.2006.07.016","article-title":"Seminal plasma cytokines and chemokines in prostate inflammation: interleukin 8 as a predictive biomarker in chronic prostatitis\/chronic pelvic pain syndrome and benign prostatic hyperplasia","volume":"51","author":"Penna","year":"2007","journal-title":"Eur. Urol."},{"issue":"7","key":"10.1016\/j.diff.2011.04.005_bib71","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.4049\/jimmunol.0801875","article-title":"Human benign prostatic hyperplasia stromal cells as inducers and targets of chronic immuno-mediated inflammation","volume":"182","author":"Penna","year":"2009","journal-title":"J. Immunol."},{"issue":"24","key":"10.1016\/j.diff.2011.04.005_bib30","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/jnci\/djj499","article-title":"Statin drugs and risk of advanced prostate cancer","volume":"98","author":"Platz","year":"2006","journal-title":"J. Natl. Cancer Inst."},{"issue":"7","key":"10.1016\/j.diff.2011.04.005_bib29","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1002\/ijc.23715","article-title":"Association between plasma cholesterol and prostate cancer in the PSA era","volume":"123","author":"Platz","year":"2008","journal-title":"Int. J. Cancer"},{"issue":"11","key":"10.1016\/j.diff.2011.04.005_bib40","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1158\/1055-9965.EPI-09-0472","article-title":"Men with low serum cholesterol have a lower risk of high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial","volume":"18","author":"Platz","year":"2009","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"1","key":"10.1016\/j.diff.2011.04.005_bib18","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1006\/dbio.1999.9229","article-title":"Prostate development requires Sonic hedgehog expressed by the urogenital sinus epithelium","volume":"209","author":"Podlasek","year":"1999","journal-title":"Dev. Biol."},{"issue":"43","key":"10.1016\/j.diff.2011.04.005_bib28","doi-asserted-by":"crossref","first-page":"6465","DOI":"10.1038\/sj.onc.1208802","article-title":"PKB\/Akt induces transcription of enzymes involved in cholesterol and fatty acid biosynthesis via activation of SREBP","volume":"24","author":"Porstmann","year":"2005","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.diff.2011.04.005_bib114","doi-asserted-by":"crossref","first-page":"7598","DOI":"10.1073\/pnas.112191399","article-title":"Symptomatic and asymptomatic benign prostatic hyperplasia: molecular differentiation by using microarrays","volume":"99","author":"Prakash","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.diff.2011.04.005_bib82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1386.009","article-title":"The role of estrogens in normal and abnormal development of the prostate gland","volume":"1089","author":"Prins","year":"2006","journal-title":"Ann. N.Y. Acad. Sci."},{"issue":"3","key":"10.1016\/j.diff.2011.04.005_bib11","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.cmet.2009.01.006","article-title":"Adipocyte CREB promotes insulin resistance in obesity","volume":"9","author":"Qi","year":"2009","journal-title":"Cell Metab."},{"issue":"8","key":"10.1016\/j.diff.2011.04.005_bib66","doi-asserted-by":"crossref","first-page":"4542","DOI":"10.1158\/0008-5472.CAN-05-4428","article-title":"Prevention of azoxymethane-induced colon cancer by combination of low doses of atorvastatin, aspirin, and celecoxib in F 344 rats","volume":"66","author":"Reddy","year":"2006","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.diff.2011.04.005_bib112","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1210\/en.136.2.741","article-title":"Evidence for atrophy and apoptosis in the ventral prostate of rats given the 5 alpha-reductase inhibitor finasteride","volume":"136","author":"Rittmaster","year":"1995","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.diff.2011.04.005_bib111","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1210\/jc.81.2.814","article-title":"Evidence for atrophy and apoptosis in the prostates of men given finasteride","volume":"81","author":"Rittmaster","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.diff.2011.04.005_bib103","first-page":"47","article-title":"Evidence that nutritional state and well-being are involved in the prostate response to certain polyene macrolides","volume":"9","author":"Robb","year":"1971","journal-title":"Invest. Urol."},{"issue":"1","key":"10.1016\/j.diff.2011.04.005_bib5","first-page":"14","article-title":"Current medical therapies for men with lower urinary tract symptoms and benign prostatic hyperplasia: achievements and limitations","volume":"10","author":"Roehrborn","year":"2008","journal-title":"Rev. Urol."},{"issue":"1","key":"10.1016\/j.diff.2011.04.005_bib12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.bbamem.2008.08.022","article-title":"Ordering effects of cholesterol and its analogues","volume":"1788","author":"Rog","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.diff.2011.04.005_bib61","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1046\/j.1464-410X.2003.04277.x","article-title":"Cardiovascular risk factors correlate with prostate size in men with bladder outlet obstruction","volume":"92","author":"Sandfeldt","year":"2003","journal-title":"Br. J. Urol. Int."},{"issue":"40","key":"10.1016\/j.diff.2011.04.005_bib73","doi-asserted-by":"crossref","first-page":"38214","DOI":"10.1074\/jbc.C300252200","article-title":"Essential requirement of apolipoprotein J (clusterin) signaling for IkappaB expression and regulation of NF-kappaB activity","volume":"278","author":"Santilli","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.diff.2011.04.005_bib106","first-page":"279","article-title":"Prostatic cholesterol metabolism: regulation and alteration","volume":"75A","author":"Schaffner","year":"1981","journal-title":"Prog. Clin. Biol. Res."},{"issue":"1","key":"10.1016\/j.diff.2011.04.005_bib90","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1073\/pnas.61.1.36","article-title":"The hypocholesterolemic activity of orally administered polyene macrolides","volume":"61","author":"Schaffner","year":"1968","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"9364","key":"10.1016\/j.diff.2011.04.005_bib45","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0140-6736(03)12948-0","volume":"361","author":"Sever","year":"2003","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.diff.2011.04.005_bib35","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/aje\/kwi203","article-title":"Statins and prostate cancer risk: a case-control study","volume":"162","author":"Shannon","year":"2005","journal-title":"Am. J. Epidemiol."},{"issue":"5497","key":"10.1016\/j.diff.2011.04.005_bib13","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1126\/science.290.5497.1721","article-title":"How cells handle cholesterol","volume":"290","author":"Simons","year":"2000","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.diff.2011.04.005_bib51","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.2353\/ajpath.2009.080551","article-title":"Ezetimibe is an inhibitor of tumor angiogenesis","volume":"174","author":"Solomon","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.diff.2011.04.005_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ucl.2011.04.001","article-title":"The complex interplay between cholesterol and prostate malignancy","author":"Solomon","year":"2011","journal-title":"Uro. Clin. N. America"},{"issue":"3","key":"10.1016\/j.diff.2011.04.005_bib98","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/0090-4295(75)90750-5","article-title":"Candicidin: physiologic effect on prostate","volume":"6","author":"Sporer","year":"1975","journal-title":"Urology"},{"key":"10.1016\/j.diff.2011.04.005_bib58","doi-asserted-by":"crossref","unstructured":"St Sauver, J.L., Jacobsen, S.J., Jacobson, D.J., McGree, M.E., Girman, C.J., Nehra, A., Roger, V.L., Lieber, M.M., 2011. Statin use and decreased risk of benign prostatic enlargement and lower urinary tract symptoms. Br. J. Urol. Int. 107 (3), 443\u2013450.","DOI":"10.1111\/j.1464-410X.2010.09598.x"},{"issue":"5","key":"10.1016\/j.diff.2011.04.005_bib57","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1590\/S1677-55382008000500003","article-title":"The effects of lovastatin on conventional medical treatment of lower urinary tract symptoms with finasteride","volume":"34","author":"Stamatiou","year":"2008","journal-title":"Int. Braz. J. Urol."},{"issue":"7","key":"10.1016\/j.diff.2011.04.005_bib86","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/jnci\/dji070","article-title":"Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk","volume":"97","author":"Sun","year":"2005","journal-title":"J. Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.diff.2011.04.005_bib104","first-page":"90","article-title":"The effects of amphotericin B on prostatic and testicular function in the dog","volume":"7","author":"Texter","year":"1969","journal-title":"Invest. Urol."},{"issue":"2","key":"10.1016\/j.diff.2011.04.005_bib99","first-page":"130","article-title":"Evaluation of a polyene macrolide: nystatin","volume":"65","author":"Theodorides","year":"1972","journal-title":"Proc. R. Soc. Med."},{"issue":"2","key":"10.1016\/j.diff.2011.04.005_bib67","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.atherosclerosis.2008.03.025","article-title":"Atherogenesis and the humoral immune response to modified lipoproteins","volume":"200","author":"Virella","year":"2008","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.diff.2011.04.005_bib91","first-page":"66","article-title":"Effect of candicidin and colestipol on the testes and prostate glands of BIO 87.20 hamsters","volume":"14","author":"Wang","year":"1976","journal-title":"Invest. Urol."},{"key":"10.1016\/j.diff.2011.04.005_bib87","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1128\/JB.89.2.306-312.1965","article-title":"Effect of cholesterol on the sensitivity of mycoplasma laidlawii to the polyene antibiotic filipin","volume":"89","author":"Weber","year":"1965","journal-title":"J. Bacteriol."},{"issue":"3","key":"10.1016\/j.diff.2011.04.005_bib1","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S0022-5347(01)66359-6","article-title":"Sickness impact of chronic nonbacterial prostatitis and its correlates","volume":"155","author":"Wenninger","year":"1996","journal-title":"J. Urol."},{"issue":"51","key":"10.1016\/j.diff.2011.04.005_bib25","doi-asserted-by":"crossref","first-page":"51125","DOI":"10.1074\/jbc.M304332200","article-title":"Cholesterol depletion results in site-specific increases in epidermal growth factor receptor phosphorylation due to membrane level effects. Studies with cholesterol enantiomers","volume":"278","author":"Westover","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.diff.2011.04.005_bib84","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1086\/345802","article-title":"Common sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk","volume":"72","author":"Xu","year":"2003","journal-title":"Am. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.diff.2011.04.005_bib100","first-page":"45","article-title":"Effect of polyene macrolide administration on prostatic hypertrophy","volume":"18","author":"Yamamoto","year":"1972","journal-title":"Hinyokika Kiyo"},{"issue":"9","key":"10.1016\/j.diff.2011.04.005_bib16","doi-asserted-by":"crossref","first-page":"5620","DOI":"10.1074\/jbc.M809172200","article-title":"Sonic hedgehog-responsive genes in the fetal prostate","volume":"284","author":"Yu","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.diff.2011.04.005_bib85","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1158\/0008-5472.CAN-03-3280","article-title":"Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: results from the CAncer Prostate in Sweden Study","volume":"64","author":"Zheng","year":"2004","journal-title":"Cancer Res."},{"issue":"18 Pt. 1","key":"10.1016\/j.diff.2011.04.005_bib65","doi-asserted-by":"crossref","first-page":"5480","DOI":"10.1158\/1078-0432.CCR-07-0242","article-title":"Atorvastatin and celecoxib inhibit prostate PC-3 tumors in immunodeficient mice","volume":"13","author":"Zheng","year":"2007","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.diff.2011.04.005_bib24","first-page":"2227","article-title":"Cholesterol-rich lipid rafts mediate akt-regulated survival in prostate cancer cells","volume":"62","author":"Zhuang","year":"2002","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.diff.2011.04.005_bib23","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1172\/JCI200519935","article-title":"Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts","volume":"115","author":"Zhuang","year":"2005","journal-title":"J. Clin. Invest."}],"container-title":["Differentiation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301468111000624?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301468111000624?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T06:07:44Z","timestamp":1638338864000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301468111000624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":115,"journal-issue":{"issue":"4-5","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0301468111000624"],"URL":"https:\/\/doi.org\/10.1016\/j.diff.2011.04.005","relation":{},"ISSN":["0301-4681"],"issn-type":[{"value":"0301-4681","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}